Genetic Technologies Limited (GENE) Financials

NASDAQ Currency in USD Disclaimer

$0.77

north_east NA Past Year
Day's range
$0.77
Day's range
$0.77

GENE Income statement / Annual

Last year (2024), Genetic Technologies Limited's total revenue was $7.66 M, a decrease of 25.93% from the previous year. In 2024, Genetic Technologies Limited's net income was -$12.02 M. See Genetic Technologies Limited,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 06/30/2024 06/30/2023 06/30/2022 06/30/2021 06/30/2020 06/30/2019 06/30/2018 06/30/2017 06/30/2016 06/30/2015
Operating Revenue $7.66 M $10.35 M $6.79 M $120,554.00 $837,865.00 $25,444.00 $189,254.00 $518,506.00 $824,586.00 $2.01 M
Cost of Revenue $3.76 M $4.34 M $321,223.00 $361,027.00 $101,433.00 $276,267.00 $300,088.00 $492,417.00 $743,060.00 $1.33 M
Gross Profit $3.90 M $6.01 M $6.47 M -$240,473.00 $736,432.00 -$250,823.00 -$110,834.00 $26,089.00 $81,526.00 $685,257.00
Gross Profit Ratio 0.51 0.58 0.95 -1.99 0.88 -9.86 -0.59 0.05 0.1 0.34
Research and Development Expenses $752,754.00 $1.28 M $705,507.00 $3.11 M $865,627.00 $2.36 M $2.21 M $2.37 M $2.69 M $2.85 M
General & Administrative Expenses $10.22 M $1.36 M $2.18 M $4.16 M $2.04 M $3.83 M $3.02 M $3.11 M $3.00 M $4.22 M
Selling & Marketing Expenses $2.61 M $2.95 M $1.89 M $1.12 M $279,312.00 $576,077.00 $1.07 M $2.72 M $3.19 M $4.50 M
Selling, General & Administrative Expenses $12.83 M $10.80 M $4.07 M $5.28 M $4.38 M $4.41 M $4.08 M $5.83 M $6.19 M $8.73 M
Other Expenses -$9.67 M $45,720.00 -$1.49 M $116,271.00 -$799,452.00 $137,268.00 $0.00 $0.00 $58,002.00 $564,821.00
Operating Expenses $3.90 M $18.11 M $3.11 M $7.00 M $6.98 M $6.18 M $5.34 M $8.44 M $8.58 M $9.27 M
Cost And Expenses $16.21 M $22.45 M $3.43 M $7.36 M $7.08 M $6.46 M $5.64 M $8.93 M $9.32 M $10.60 M
Interest Income -$272,116.00 $190,646.00 $36,256.00 $62,394.00 $49,555.00 $5,763.00 $13,625.00 $6,770.00 $38,211.00 $224,743.00
Interest Expense $51,622.00 $29,515.00 $15,215.00 $14,049.00 $14,823.00 $20,031.00 $28,843.00 $31,995.00 $28,889.00 $264,694.00
Depreciation & Amortization $534,888.00 $676,583.00 $578,668.00 $478,222.00 $265,933.00 $156,248.00 $303,749.00 $371,611.00 $390,074.00 $232,203.00
EBITDA -$11.43 M -$11.20 M -$7.20 M -$7.06 M -$5.87 M -$6.86 M -$5.46 M -$7.80 M -$8.10 M -$8.42 M
EBITDA Ratio -1.49 -0.97 -0.55 -58.59 -7.01 -269.67 -32.23 -15.04 -9.83 -4.79
Operating Income Ratio -0.85 -1.01 -1.11 -61.56 -7.09 -275.82 -33.84 -15.76 -10.3 -4.9
Total Other Income/Expenses Net -$5.48 M -$1.49 M -$2.35 M $343,942.00 -$1.90 M $592,256.00 $939,682.00 -$232,577.00 $336,122.00 $1.06 M
Income Before Tax -$12.02 M -$11.91 M -$7.16 M -$7.08 M -$6.29 M -$6.43 M -$5.46 M -$8.40 M -$8.46 M -$8.81 M
Income Before Tax Ratio -1.57 -1.15 -1.05 -58.71 -7.51 -252.54 -28.87 -16.21 -10.26 -4.38
Income Tax Expense $0.00 $158,329.00 -$32,125.00 -$135,428.00 -$750,000.00 -$856,707.00 -$299,351.00 -$253,159.00 -$359,803.00 $0.00
Net Income -$12.02 M -$11.75 M -$7.13 M -$7.08 M -$6.29 M -$6.43 M -$5.46 M -$8.40 M -$8.46 M -$8.81 M
Net Income Ratio -1.57 -1.14 -1.05 -58.71 -7.51 -252.54 -28.87 -16.21 -10.26 -4.38
EPS -0.0909 -0.36 -0.2319 -0.2484 -0.45 -0.69 -0.66 -1.2 -1.47 -2.46
EPS Diluted -0.0909 -0.36 -0.2319 -0.2484 -0.45 -0.69 -0.66 -1.2 -1.47 -2.46
Weighted Average Shares Out $132.22 M $3.38 M $3.07 M $2.85 M $1.38 M $940,292.67 $810,949.14 $706,505.75 $571,166.33 $357,243.53
Weighted Average Shares Out Diluted $132.22 M $3.38 M $3.07 M $2.85 M $1.38 M $940,292.67 $810,949.14 $706,505.75 $571,166.33 $357,243.53
Link